Letter: case noteLong-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations
References (7)
- et al.
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
Blood
(1994) - et al.
Humoral immunity due to long-lived plasma cells
Immunity
(1998) - et al.
Correlation between profile of circulating mononuclear cells and clinical manifestations in patients with pemphigus vulgaris
Autoimmunity
(2000)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.